AMT Medical funding news – Netherlands-based AMT Medical Raises €22Million in Series B Round Funding

Apr 17, 2025 | By Team SR

Netherlands-based AMT Medical has raised €22 million in Series B funding to speed up the development and launch of its heart bypass technology.

SUMMARY

Netherlands-based AMT Medical has raised €22 million in Series B funding to speed up the development and launch of its heart bypass technology.
AMT Medical, founded in 2015, is developing a new method for heart bypass surgery.

The round included a €5 million investment from Invest-NL, a Dutch investor that supports innovation. It was led by Bender Analytical Holding, with participation from Oost NL, the European Innovation Council (EIC), and other private investors.

The funding from Invest-NL will help AMT Medical get CE certification, run clinical trials in the Netherlands and abroad, and get ready to enter the market.

RECOMMENDED FOR YOU

Funding

Smart Robotics Raises €10M Series A To Scale AI Warehouse Automation In Europe

Oliver Bennett

Apr 21, 2026

Ireland

AI Fleet Intelligence Startup CameraMatics Bags Up to €49M for Expansion

Oliver Bennett

Jun 11, 2026

Appointment

Signadori Bio Appoints Dr. Selwyn Ho, MB BS As Chief Executive Officer

Kailee Rainse

Mar 31, 2026

This investment supports Invest-NL’s goal of making healthcare more affordable, accessible, and less dependent on staff.

About AMT Medical

AMT Medical, founded in 2015, is developing a new method for heart bypass surgery. Its Elana Heart Bypass technology allows doctors to perform the procedure without opening the chest or stopping the heart. Instead of stitches, it uses a special clip and laser to connect blood vessels.

The system works with surgical robots and enables consistent, less invasive surgeries. This makes it possible to treat more patients, including those who can't undergo traditional open-heart surgery.